noscript

News and Announcements

OncoSil Medical Quarterly Activities & Cash Flow Report June 2016

  • Published July 27, 2016 11:38AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

27th July 2016, ASX Announcement

OncoSil Medical Ltd (ASX: OSL) (Oncosil of the Company), a late stage medical devices company focused on localised treatments for patients with pancreatic and liver cancer today released its Appendix 4C – Quarterly Cashflow report for the quarter ended 30 June 2016 (the Quarter). All financial results are in Australian dollars and are unaudited.

Highlights for the Quarter

  • Filed IDE Amendment with u.S. FDA
  • Further submission to the Notified Body for CE mark applicatiopn responding to all questions
  • Michael Warrener, appointed Global Head of Sale and Marketing
  • All 30 June 2016 options exercised for cash, with recipts of $0.9m
  • Cash outflow form Operations of $2.0m for the Quarter – closing cash balance of $13.4m

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now